Vaneck UCITS ETFs PLC - Vaneck Genomics And Healthcare Innovators UCITS ETF (SWX:CURE)
Switzerland · Delayed Price · Currency is CHF 22.69
+0.40 (1.82%)
Last updated: Sep 22, 2026, 11:19 AM CET
SWX:CURE Holdings Information
SWX:CURE is an equity ETF with a total of 57 individual holdings. The top holdings are Moderna stock at 11.47%, Natera at 8.16%, Regeneron Pharmaceuticals at 7.79%, Veeva Systems at 7.17%, and Vertex Pharmaceuticals at 7.03%.
Total Holdings
57
Top 10 Percentage
64.90%
Asset Class
Equity
ETF Category
Theme
Assets
17.46M
PE Ratio
28.49
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | MRNA | Moderna, Inc. | 11.47% |
| 2 | NTRA | Natera, Inc. | 8.16% |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 7.79% |
| 4 | VEEV | Veeva Systems Inc. | 7.17% |
| 5 | VRTX | Vertex Pharmaceuticals Incorporated | 7.03% |
| 6 | DXCM | DexCom, Inc. | 6.11% |
| 7 | ILMN | Illumina, Inc. | 5.60% |
| 8 | GH | Guardant Health, Inc. | 4.68% |
| 9 | BNTX | BioNTech SE | 3.46% |
| 10 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.44% |
| 11 | QGEN | Qiagen N.V. | 2.03% |
| 12 | PODD | Insulet Corporation | 2.02% |
| 13 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.00% |
| 14 | ASX: PME | Pro Medicus Limited | 1.90% |
| 15 | HKG: 1548 | Genscript Biotech Corporation | 1.74% |
| 16 | TXG | 10x Genomics, Inc. | 1.50% |
| 17 | HKG: 6618 | JD Health International Inc. | 1.40% |
| 18 | CGON | CG Oncology, Inc. | 1.38% |
| 19 | CRSP | CRISPR Therapeutics AG | 1.29% |
| 20 | KRYS | Krystal Biotech, Inc. | 1.29% |
| 21 | IONS | Ionis Pharmaceuticals, Inc. | 1.29% |
| 22 | HIMS | Hims & Hers Health, Inc. | 1.28% |
| 23 | HNGE | Hinge Health, Inc. | 1.28% |
| 24 | STO: SECT.B | Sectra AB (publ) | 1.12% |
| 25 | TYO: 2413 | M3, Inc. | 1.11% |
As of Sep 17, 2026